Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.» Read More
Sustainability isn’t just about saving the planet. It's about opportunity—reinventing business models to better compete in the global economy.
Yeah, right. Actually, the working sessions and panels are better attended than any conference I've ever seen.
Joe's pee smells after he eats asparagus. That's what he announced to me, and the rest of the world, on Squawk this morning.
While we're spending hundreds of billions to bail out financial institutions, why not also bail in the future by investing more in science and technology?
Do you know where your federal income-tax dollars go? The National Priorities Project does. Learn how each dollar is spent when it gets into Uncle Sam's hands.
Swiss drugmaker Roche has submitted its experimental Actemra drug to the U.S. authorities for approval to treat moderate to severe rheumatoid arthritis in adults.
Medical device maker Boston Scientific is preparing to slash thousands of jobs to counter slumping sales, according to a media report Tuesday.
Americans Leonid Hurwicz, Eric Maskin and Roger Myerson won the Nobel Memorial Prize in Economic Sciences on Monday for their work that "laid the foundations of mechanism design theory."
EU farm ministers fell short of a consensus agreement on Wednesday to allow imports of three genetically modified (GMO) maize types, again revealing their deep differences on GMO crops and foods, officials said.
In a scientific tie-in to the new Picture film "Ratatouille" (do scientists do this on purpose?) lab humans observing lab rats have determined that rats who've been helped in the past "pay it forward." This is, they claim, the first proof of "indirect reciprocity" in non-humans. In other words, rats that were helped in the past are more likely to help a stranger in the future. The report was published in Los Biology, an online open access journal (the same place I found the stuff about fruitflies having free will--what a gold mine that site is).
The company built by the world's richest man takes on the world's largest democracy, and it's a case of cyber culture clash. India-based itVAR News (an IT website) says Microsoft is billing computer retailers in the town of Gujarat thousands of dollars, accusing them of installing pirated Windows software.The retailers have responded with a strike, a boycott and general outrage, though no one appears to be denying the accusations. One Indian retailer put it this way, "Since we are not charging anything extra for installing the software, it means that we are actually not trading in pirated software. For us, this is just a 'sewa' (selfless act) that we are offering to our customers. Besides, the pricing of their operating systems is way too high for Indian markets."
Someone please email me at firstname.lastname@example.org to explain how the following research can benefit humankind. I will post interesting replies, and the reader with the best explanation will win a CNBC cap (I know I have one around here somewhere).A group of researchers has determined that fruit flies have free will. It's comforting to know, I guess. How did the scientists figure this out? They put the flies in a uniformly-white environment, and then tethered their legs and watched them move.
A French-built high-speed train has broken the world speed record on rail: With a 25,000 horsepower engine and special wheels, the train hit a speed of more than 357 mph. The train’s performance was close -- but was not as fast as the Japanese maglev (magnetic) train that reached 361 mph in 2003. CNBC’s Phil Lebeau joined Erin Burnett on "Street Signs" to discuss why the U.S. can’t -- or won't -- do the same thing.
Are humans responsible for global warming--or not? A new report says--yes. Scientists from 113 countries issued the report Friday--saying they have little doubt global warming is caused by man, and predicting that hotter temperatures and rises in sea level will “continue for centuries” no matter how much humans control their pollution.
Pfizer stock is down 13% so far today on news that development of its Lipitor successor – torceptrapib – has been halted. Analysts have downgraded the stock and cut price targets as a result. Barbara Ryan – managing director and senior analyst at Deutsche Bank – disagrees though. She appeared on “Morning Call” to say that the dip in price today is a buy-in opportunity.